 MD Medical DiagnosticsUsing ultrasound technology as a basis for detecting cancer, the company's revolutionary software is able to provide a 3-D overlay with visual analysis of imaging, showing cancer locations and sizes at a greater accuracy and much cheaper than other available technologies. |  OmrixA marketing stage biotechnology company that develops and markets a unique surgical sealant, as well as a suite of other plasma-derivative products. Omrix IPO'd on the NASDAQ in 2006 and was sold to Johnson & Johnson in 2008. |
---|